Private equity eyes Pacific Smiles as EGM looms

SURFERS PARADISE: Private equity firms Crescent Capital and BGH Capital are expected to ... read more

BiomeBank has raised $10.7m to fast-track Crohn’s disease treatment

ADELAIDE: BiomeBank has raised $10.65m with the Adelaide-based biotechnology company to use the ... read more

Cochlear acquisition deal sparks ACCC competition concerns

MELBOURNE: Cochlear’s proposed $170 million acquisition of a Danish hearing loss device maker ... read more

Healius dives as Covid-19 boom times end for pathology giants

MELBOURNE: Healius shares have dived more than 10 per cent after it revealed ... read more